Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$2.61
-7.4%
$4.05
$2.11
▼
$6.40
$97.95M-0.0290,602 shs120,132 shs
Inogen, Inc stock logo
INGN
Inogen
$5.31
-2.1%
$6.03
$5.05
▼
$7.67
$137.93M1.51295,961 shs266,097 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$62.19
-2.0%
$64.91
$30.55
▼
$77.00
$199.01M0.1250,187 shs44,150 shs
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
$0.99
-11.3%
$1.16
$0.28
▼
$3.85
$35.73M3.9711.43 million shs2.58 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
-9.03%-17.30%-32.86%-31.72%+281,999,900.00%
Inogen, Inc stock logo
INGN
Inogen
-2.69%-3.56%-18.98%-3.39%-18.98%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.70%-5.83%+6.89%-3.32%+119.61%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
0.00%-5.88%-23.29%+22.34%+111,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$2.61
-7.4%
$4.05
$2.11
▼
$6.40
$97.95M-0.0290,602 shs120,132 shs
Inogen, Inc stock logo
INGN
Inogen
$5.31
-2.1%
$6.03
$5.05
▼
$7.67
$137.93M1.51295,961 shs266,097 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$62.19
-2.0%
$64.91
$30.55
▼
$77.00
$199.01M0.1250,187 shs44,150 shs
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
$0.99
-11.3%
$1.16
$0.28
▼
$3.85
$35.73M3.9711.43 million shs2.58 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
-9.03%-17.30%-32.86%-31.72%+281,999,900.00%
Inogen, Inc stock logo
INGN
Inogen
-2.69%-3.56%-18.98%-3.39%-18.98%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.70%-5.83%+6.89%-3.32%+119.61%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
0.00%-5.88%-23.29%+22.34%+111,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FOCL
FocalTherics
2.50
Moderate Buy$9.67270.37% Upside
Inogen, Inc stock logo
INGN
Inogen
2.50
Moderate BuyN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2.67
Moderate Buy$80.0028.64% Upside
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest QTEX, PDEX, INGN, and FOCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Boost Price TargetBuy$74.00 ➝ $80.00
11/10/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B-)
11/9/2026
FOCL
FocalTherics
DowngradeSell (D-) ➝ Sell (E+)
11/9/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeStrong-Buy ➝ Hold
11/3/2026
Inogen, Inc stock logo
INGN
Inogen
Reiterated RatingSell (D-)
10/23/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B) ➝ Hold (C+)
10/9/2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
DowngradeSell (D-) ➝ Sell (E+)
10/8/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B)
9/25/2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
UpgradeSell (E+) ➝ Sell (D-)
9/21/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-) ➝ Hold (C+)
9/15/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold ➝ Strong-Buy
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FOCL
FocalTherics
$70.53M1.39N/AN/A$0.96 per share2.72
Inogen, Inc stock logo
INGN
Inogen
$348.67M0.40N/AN/A$6.04 per share0.88
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$77.55M2.57$3.80 per share16.38$15.42 per share4.03
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
$290K123.22N/AN/A$0.06 per share16.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FOCL
FocalTherics
-$29.25M-$0.98N/AN/AN/A-59.77%-223.32%-41.32%N/A
Inogen, Inc stock logo
INGN
Inogen
-$22.75M-$1.31N/AN/AN/A-10.46%-19.29%-12.02%N/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$13.66M$3.6517.0418.51N/A15.12%26.18%16.69%2/4/2027 (Estimated)
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
-$13.22MN/AN/AN/AN/AN/AN/AN/AN/A

Latest QTEX, PDEX, INGN, and FOCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
FOCL
FocalTherics
-$0.18-$0.10+$0.08-$0.10N/A$9.83 million
11/5/2026Q3 2026
Inogen, Inc stock logo
INGN
Inogen
-$0.1423-$0.56-$0.4177-$0.61$92.25 million$77.19 million
10/29/2026Q1 2027
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.92+$0.25$0.92$20.40 million$20.56 million
9/24/2026Q2 2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
N/A-$0.07N/A-$0.07N/A$0.78 million
9/3/2026Q4 2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.87+$0.20$0.87$19.20 million$20.41 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
FOCL
FocalTherics
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FOCL
FocalTherics
0.98
2.63
2.40
Inogen, Inc stock logo
INGN
Inogen
N/A
2.96
2.55
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.25
4.19
2.49
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
0.12
2.00
1.62

Institutional Ownership

CompanyInstitutional Ownership
FOCL
FocalTherics
62.74%
Inogen, Inc stock logo
INGN
Inogen
89.94%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
12.72%

Insider Ownership

CompanyInsider Ownership
FOCL
FocalTherics
10.10%
Inogen, Inc stock logo
INGN
Inogen
2.50%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
48.00%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
29.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
FOCL
FocalTherics
23037.53 million33.74 millionOptionable
Inogen, Inc stock logo
INGN
Inogen
75326.00 million25.35 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2063.20 million1.66 millionNot Optionable
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
4135.95 million25.38 millionN/A

Recent News About These Companies

QTREX Quantum Ltd. Ordinary Shares (QTEX) Earnings
QTREX Quantum Ltd. (QTEX)
Correction: QTREX Quantum Announces Clean Capital Structure
QTREX Quantum Announces Clean Capital Structure
QTREX receives Nasdaq non-compliance notice
QTREX Quantum Stock Climbs Friday: What's Going On?
QTREX Quantum Reports First Half 2026 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

FocalTherics NASDAQ:FOCL

$2.61 -0.21 (-7.45%)
As of 03:46 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Inogen stock logo

Inogen NASDAQ:INGN

$5.30 -0.12 (-2.12%)
Closing price 03:59 PM Eastern
Extended Trading
$5.30 0.00 (0.00%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$63.65 +0.16 (+0.26%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

QTREX Quantum stock logo

QTREX Quantum NASDAQ:QTEX

$0.99 -0.13 (-11.25%)
Closing price 03:58 PM Eastern
Extended Trading
$0.99 0.00 (-0.20%)
As of 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.